Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Financial Performance and Strategy news
(page 5)
29 April 2026
GSK Q1 2026 — Specialty Medicines Drive Growth
Q1 sales £7.6bn (+5% CER); Specialty Medicines £3.2bn (+14%). Core operating profit +10%, Core EPS +9%. Strong cash generation; 17p Q1 dividend. 2026 guidance and >£40bn 2031 target reaffirmed.
29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed
Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share
29 April 2026
UPM approves Plywood demerger to create listed WISA Group
Board approved plan to spin off a business into a new listed company; EGM approval pending; 1:1 share distribution; target completion Oct 31, 2026; listing expected early Nov 2026.
29 April 2026
ROSI raises €20m+ to scale PV recycling in Europe
€20M+ plus EU grants to fund industrial expansion: 10,000 t/yr solar-panel recycling plant in Spain, scalable automated line, new production director appointed, recycling partnership renewed
29 April 2026
BASF’s industrial Cathedral and the ground it stands on
Integrated site captured synergies for decades—cutting costs, funding R&D—but gas-price shock in 2022 exposed systemic risk; response: restructure Ludwigshafen and expand production abroad.
29 April 2026
UPM Q1 2026: Strong start led by decarbonization solutions
Q1 sales €2,505m; comparable EBIT €274m (-5%); operating cash flow €89m; net debt €2,962m. Energy and biofuels strong. H1 comparable EBIT guidance €325–525m.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
29 April 2026
FUCHS starts 2026 strongly amid volatile markets
Q1 sales +1% to €934m; record EBIT €125m; EPS €0.68 (+15%). FY EBIT target €450m confirmed; sales guidance above €3.7bn. Raw‑material and supply risks weigh on cash flow.
29 April 2026
TotalEnergies completes 50% acquisition of EPH flexible power portfolio in Europe
Creates TTEP: 14 GW flexible gas/biomass + BESS across Italy, UK, Ireland, Netherlands, France; ~30 TWh output in 2025; tolling contracts; 5 GW development pipeline.
29 April 2026
TotalEnergies Q1 2026 Results
Press release (Paris, Apr 29, 2026) announcing financial results; links to full details and investor information.
29 April 2026
Symrise Q1 2026: Organic sales -0.4%, full-year outlook reaffirmed
Strength in Food & Beverage, Pet Food, Fragrance; Taste, Nutrition & Health +1.7%, Scent & Care -3.4%. ONE SYM driving cost savings and reinvestment; APAC & Americas up, EMEA down
29 April 2026
Neste Q1 2026 Interim Report
Strong Q1: comparable EBITDA EUR 861m; cash flow before financing EUR 286m; renewable margin USD 856/t; oil refining margin USD 23.0/bbl; leverage 31.7%; volumes hit by maintenance
28 April 2026
PPG Q1 2026 results
Q1 net sales $3.93B (+7%), organic +1% on price. Adjusted EPS $1.83 (+6%). Segment margin 16%, EBITDA margin 19%. ~$100M buybacks. Reaffirms FY EPS $7.70–8.10.
28 April 2026
Air Liquide Q1 2026: growth and record investments
Q1 sales €6.8B (+3.4% ex-currency/energy). Gas & Services +2%; Healthcare +4%. Efficiencies €142M; operating cash flow +7%. Investments €1.5B, backlog €5.5B; DIG Airgas closed; +100bps margin target 2026.
28 April 2026
bp Q1 2026 results
Q1: upstream and downstream reliability rose; underlying RC profit $3.2B; operating cash flow $2.9B after $6.0B working-cap build; net debt $25.3B; Gelsenkirchen sale agreed.
28 April 2026
dsm-firmenich sells Action Pin to AP Marensin
Announced Apr 28, 2026: sale of Action Pin (Castets, France), 110 employees, ~€50M sales in 2025; transaction pending regulatory approvals; financial terms undisclosed.
27 April 2026
Shell to acquire ARC Resources
Deal adds 370 kboe/d, lifts production CAGR to 4% to 2030, boosts low‑cost Montney liquids and gas, ~US$16.4bn enterprise value, accretive to FCF/share from 2027; closes H2 2026
27 April 2026
Lilly to acquire Ajax Therapeutics for AJ1‑11095, a first‑in‑class Type II JAK2 inhibitor
Lead program in Phase 1; POC data due late 2026. Designed to deliver deeper, more durable responses than current Type I JAK2 therapies. Deal may pay up to $2.3B, subject to closing.
27 April 2026
Galp Q1 2026 Results
Strong Q1 with €943m RCA EBITDA, Upstream €685m; net income €272m; OCF €713m; FCF €47m; net debt stable at €1.3bn; Namibia exploration & Moeve merger progressing.
27 April 2026
BASF raises plastic-additive prices up to 25%
Further price increase up to 25% for antioxidants, process and light stabilizers in plastic applications, effective immediately, citing higher raw-material, energy and logistics costs.
27 April 2026
Terumo names OrganOx segment Terumo Organ Technologies
Effective April 2026 the business segment will be renamed; the disclosure segment name will change starting with consolidated results for fiscal year ending March 2026.
24 April 2026
Iberdrola sells Mexico business
Mexico business sale completed: 2,600 MW (1,368 MW gas/cogeneration; 1,232 MW wind/solar), plus commercial ops and development projects; aligns with strategy to focus on contracted generation.
24 April 2026
Chugai Q1 FY2026 Results
Core rev ¥321.7B (+11.5%), core OP ¥163.3B (+17.1%), core net ¥118.6B (+19.6%). Launched Elevidys (DMD JP); Lunsumio+Polivy approved for LBCL. R&D: NXT007 switch, Enspryng (MOGAD), Foundayo US approval.
24 April 2026
Kemira Q1 2026: Revenue and Profitability Down; Performance Actions Accelerated
Q1 revenue and margins fell due to weak demand, pricing and FX; volumes stable. Operative EBITDA down; operating cash flow improved. Outlook unchanged; cost and pricing measures accelerated.
24 April 2026
Yara reports higher margins and strong volumes in Q1 2026
EBITDA excl. items rose to USD 896m; net income USD 327m. Middle East conflict disrupted fertilizer supply and raised prices; the company used its global model to sustain production and sourcing.
24 April 2026
Eni Q1 2026 results: raises share buyback to €2.8bn
Q1: E&P +9% to 1.8 mln boe/d; ~1bn boe discovered; FY CFFO raised to €13.8bn; Plenitude demerger, Acea adds clients to reach 11m; Enilive FIDs two biorefineries; proforma gearing 15%
23 April 2026
Honeywell Q1 Results, Reaffirms 2026 Outlook and Agrees to Sell Warehouse & Workflow Solutions
Q1: sales +2% organic, orders +7%, backlog $38.3B. Operating income -14% (impairments); segment profit +6% to $2.13B. Adjusted EPS +11% to $2.45; GAAP EPS $1.29.
23 April 2026
Dow Q1 2026 results
Q1: Net sales $9.8B (-6%); volumes -2%; local price -7%. GAAP loss $445M; operating EBIT $154M. Cash from ops $1.1B aided by NOVA payment. Sadara equity loss recognition suspended.
23 April 2026
LKAB Q1 2026: Lower earnings, weaker market
Q1 net sales MSEK 7,907 (9,622); operating profit MSEK 860 (3,638). Weaker USD, lower pellet premiums and higher energy, plus transport and mine issues reduced volumes; ~2 Mt 2026 shortfall
22 April 2026
Air Liquide invests $350M+ in Louisiana to supply gases for Hyundai‑POSCO low‑carbon steel plant
Adding an ASU at a methanol site and extending pipeline along the Mississippi to boost methanol output, enable scalable, reliable gas supply for industrial decarbonization, with service from 2028.
22 April 2026
Merck and Google Cloud launch $1B agentic AI platform using Gemini Enterprise
Multi-year collaboration embeds AI across R&D, manufacturing, commercial and corporate functions to boost productivity for 75,000 staff, speed drug development and enable predictive analytics.
← Previous
Next →
